Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer
C I Falkson, H C Falkson
Oncology
|
January 15, 1998
Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992
C I Falkson, H C Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
August 28, 1976
Leukaemia in Hodgkin's disease
H C Falkson, M A Portugal, G Falkson
Oncology
|
July 1, 1996
Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin
C I Falkson, H C Falkson, G Falkson
Investigational New Drugs
|
May 1, 1990
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer
G Falkson, M R Chasen, H C Falkson
Journal of the National Cancer Institute
|
December 18, 1996
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group
D C Tormey, R Gray, H C Falkson
Cancer
|
April 1, 1980
Non-Hodgkin's lymphoma in pregnancy
H C Falkson, I W Simson, G Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1992
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer
C I Falkson, H C Falkson, G Falkson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer
J I Raats, G Falkson, H C Falkson
Investigational New Drugs
|
January 1, 1994
Phase II trial of fotemustine in patients with metastatic malignant melanoma
C I Falkson, G Falkson, H C Falkson
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer
C I Falkson, H C Falkson
Oncology
|
January 15, 1998
Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992
C I Falkson, H C Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
August 28, 1976
Leukaemia in Hodgkin's disease
H C Falkson, M A Portugal, G Falkson
Oncology
|
July 1, 1996
Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin
C I Falkson, H C Falkson, G Falkson
Investigational New Drugs
|
May 1, 1990
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer
G Falkson, M R Chasen, H C Falkson
Journal of the National Cancer Institute
|
December 18, 1996
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group
D C Tormey, R Gray, H C Falkson
Cancer
|
April 1, 1980
Non-Hodgkin's lymphoma in pregnancy
H C Falkson, I W Simson, G Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1992
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer
C I Falkson, H C Falkson, G Falkson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer
J I Raats, G Falkson, H C Falkson
Investigational New Drugs
|
January 1, 1994
Phase II trial of fotemustine in patients with metastatic malignant melanoma
C I Falkson, G Falkson, H C Falkson
Page
of 6